Insider Trades
News
businesswire.comAdagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardiabusinesswire.comMay 21
businesswire.comAdagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progressbusinesswire.comMay 12
businesswire.comAdagio Medical to Participate in the BofA Securities 2026 Health Care Conferencebusinesswire.comApr 29
businesswire.comAdagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation Systembusinesswire.comApr 26
defenseworld.netAdagio Medical Holdings, Inc. (NASDAQ:ADGM) Sees Large Growth in Short Interestdefenseworld.netApr 26